Beilstein J. Org. Chem. 2014, 10, 1808–1816.
tration required to completely inhibit the growth of the
microbes was defined as the minimum inhibitory concentration
(MIC).
Supporting Information
Supporting Information File 1
Procedures for chemical conversion/derivatization, NMR
assignments, copies of NMR, MS and UV spectra for 1,
NMR spectra for 2, 3, 3a and 3b.
Cytotoxicity testing and cell morphology
observation
The cytotoxicity against 3Y1-B clone 1-6 rat fibroblasts and the
action of sacrolide A (1) on the morphology of the same cell
line were evaluated by the procedures described in [22].
Method to precook raw alga for the elimination of sacrolide
A (1): A tablespoon of NaHCO3 (15 g) was added to a pot
containing 500 mL of water, and the solution was boiled at high
temperature. Then 40 g of raw A. sacrum was added and boiled
with occasional stirring for 1 min. The boiled alga was drained
in a colander, washed three times with cold water, and then
subjected to the extraction and fractionation procedure
described in the next section.
Acknowledgements
This work was supported in part by the President’s Fund Initia-
tive at the Toyama Prefectural University. 3Y1-B clone 1-6 rat
fibroblastic cells (resource number JCRB0734) were obtained
from the Health Science Research Resources Bank.
References
1. Chlipala, G. E.; Mo, S.; Orjala, J. Curr. Drug Targets 2011, 12,
2. Tan, L. T. Phytochemistry 2007, 68, 954–979.
Evaluation of the presence of sacrolide A (1) in two
commercial products and precooked sample of A. sacrum:
Dry or brined alga was soaked in water for 30 min and weighed
prior to extraction. A 20 g portion from each product,
precooked or raw alga, was extracted with EtOH, and the
extracts were separated by solvent partitioning into four frac-
tions soluble in n-hexane, aqueous 90% MeOH, 1-BuOH, and
water. The yields were: 33.2 mg, 12.0 mg, 12.7 mg, and
51.2 mg from dry alga; 10.9 mg, 8.1 mg, 9.8 mg, and 25.3 mg
from brined alga; 10.6 mg, 5.0 mg, 16.4 mg, and 80.6 mg from
precooked alga; and 19.6 mg, 17.8 mg, 12.7 mg, and 22.6 mg
from raw alga. The fractions were subjected to antifungal
susceptibility testing by using the paper-disk agar diffusion
method and LC–MS analysis to evaluate the presence of 1.
Given a dose of 200 μg/disk none of the fractions from the
commercial products or precooked sample exhibited an activity
against Penicillium chrysogenum, whereas the aqueous 90%
MeOH fraction from raw alga exhibited an inhibition circle
with a diameter of 12.0 mm, which indicates the presence of 1.
The LC–MS analysis was conducted with a Cosmosil AR-II
column (Nacalai Tesque, 2.0 mm × 150 mm) under the elution
program of 40% MeCN for 5 min, 1%/min MeCN concentra-
tion ramped to 100%. The concentration was held for 10 min at
a flow rate of 0.2 mL/min at 35 °C. Ten μL aliquots from
10 μg/mL DMSO solution of authentic 1 and 1 mg/mL DMSO
solution of the aqueous 90% MeOH fraction from each algal
sample were injected, and negative ESI was employed for mass
spectral detection. The authentic 1 eluted at 23.6 min, showing
a negative molecular ion at m/z 307. Based on this result, total
ion chromatograms for the analytes were edited by extracting an
m/z 307 ± 0.5 signal, which presented elution of 1 from the raw
alga sample. In contrast, other samples were devoid of 1.
4. Oku, N.; Yonejima, K.; Sugawa, T.; Igarashi, Y.
Biosci., Biotechnol., Biochem. 2014, 78, 1147–1150.
5. Kabata, K.; Okamoto, C.; Sasada, N.; Ono, M.; Igoshi, K.;
Kobayashi, K.; Masuoka, C.; Ito, Y.
Proc. Fac. Agric., Kyushu Tokai Univ. 2005, 24, 37–43.
6. Kabata, K.; Okamoto, C.; Odahara, T.; Nakazono, T.; Osumi, K.;
Sasada, N.; Ichikawa, T.; Kaneko, Y.; Aramaki, S.
Proc. Fac. Agric., Kyushu Tokai Univ. 2007, 26, 1–6.
7. Kabata, K. Suizenji-nori. In Shokuhin Kako Soran; Nohbunkyo, Ed.;
Nohsangyosonbunkakyokai: Tokyo, Japan, 2002; Vol. 12, pp 563–569.
8. Uchihira, T.; Naito, S.; Masuoka, C.; Okamoto, C.; Yasuda, S.
Proc. Fac. Agric., Kyushu Tokai Univ. 2013, 32, 7–11.
(accessed April 10, 2014).
10.Watanabe, F.; Miyamoto, E.; Fujita, T.; Tanioka, Y.; Nakano, Y.
Biosci., Biotechnol., Biochem. 2006, 70, 3066–3068.
11.Ngatu, N. R.; Okajima, M. K.; Yokogawa, M.; Hirota, R.; Eitoku, M.;
Muzembo, B. A.; Dumavibhat, N.; Takaishi, M.; Sano, S.; Kaneko, T.;
Tanaka, T.; Nakamura, H.; Suganuma, N.
Ann. Allergy, Asthma, Immunol. 2012, 108, 117–122.
12.Ödman, P.; Wessjohann, L. A.; Bornscheuer, U. T. J. Org. Chem.
13.Hatch, R. P.; Shringerpure, J.; Weinreb, S. M. J. Org. Chem. 1978, 43,
14.Oku, N.; Takada, K.; Fuller, R. W.; Wilson, J. A.; Peach, M. L.;
Pannell, L. K.; McMahon, J. B.; Gustafson, K. R. J. Am. Chem. Soc.
15.Trost, B. M.; Belletire, J. L.; Godleski, S.; McDougal, P. G.;
Balkovec, J. M.; Baldwin, J. J.; Christy, M. E.; Ponticello, G. S.;
Varga, S. L.; Springer, J. P. J. Org. Chem. 1986, 51, 2370–2374.
1815